References
- Psaty BM, Lumley T, Furberg CD, et al. Health outcomesassociated with various antihypertensive therapies used asfirst-line agents: a network meta- analysis. JAMA 2003;289: 2534–44
- Bonow RO, Smaha LA, Smith SC, Jr, et al. World HeartDay 2002: the international burden of cardiovascular disease:responding to the emerging global epidemic. Circulation 2002;106:1602–5
- Wolf HK, Tuomilehto J, Kuulasmaa K, et al. Blood pressurelevels in the 41 populations of the WHO MONICA Project.J Hum Hypertens 1997;11:733–42
- Murray CJ, Lopez AD. Global mortality, disability, and thecontribution of risk factors: Global Burden of Disease Study.Lancet 1997;349:1436–42
- Wang YR, Alexander GC, Stafford RS. Outpatienthypertension treatment, treatment intensification, and controlin Western Europe and the United States. Arch Intern Med 2007;167:141–7
- Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of tenyearrisk of fatal cardiovascular disease in Europe: the SCOREproject. Eur Heart J 2003;24:987–1003
- Neutel JM, Smith DH. Improving patient compliance: a majorgoal in the management of hypertension. J Clin Hypertens(Greenwich) 2003;5:127–32
- Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate managementof blood pressure in a hypertensive population. N Eng J Med 1998;339:1957–63
- Erkens JA, Panneman MM, Klungel OH, et al. Differences inantihypertensive drug persistence associated with drug classand gender: a PHARMO study. Pharmacoepidemiol Drug Saf 2005;14:795–803
- Degli Esposti L, Degli Esposti E, Valpiani G, et al. Aretrospective, population- based analysis of persistence withantihypertensive drug therapy in primary care practice in Italy.Clin Ther 2002;24:1347–57; discussion 6
- Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medicationnonadherence on hospitalization and mortality among patientswith diabetes mellitus. Arch Intern Med 2006;166:1836–41
- Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impactof medication adherence on hospitalization risk and healthcarecost. Med Care 2005;43:521–30
- DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patientadherence and medical treatment outcomes: a meta-analysis.Med Care 2002;40:794–811
- Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F.Relationship of blood pressure control to adherence withantihypertensive monotherapy in 13 managed care organizations.J Manag Care Pharm 2006;12: 239–45
- Catalan VS, Lelorier J. Predictors of Long-term Persistenceon Statins in a Subsidized Clinical Population. Value Health 2000;3:417–26
- 2003 European Society of Hypertension-European Societyof Cardiology guidelines for the management of arterialhypertension. J Hypertens 2003;21: 1011–53
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Reportof the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure: the JNC 7report. JAMA 2003;289:2560–72
- Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J.Predictors of uncontrolled hypertension in ambulatory patients.Hypertension 2001;38:809–14
- Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medicationadherence: a key factor in achieving blood pressure control andgood clinical outcomes in hypertensive patients. Curr OpinCardiol 2004;19:357–62
- Svensson S, Kjellgren KI, Ahlner J, Saljo R. Reasons foradherence with antihypertensive medication. Int J Cardiol 2000;76(2–3):157–63
- Osterberg L, Blaschke T. Adherence to medication. N Engl JMed 2005;353:487–97
- Giles TD. Rationale for combination therapy as initialtreatment for hypertension. J Clin Hypertens (Greenwich) 2003;5(4 Suppl 3):4–11